Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 21, 2014; 20(7): 1746-1755
Published online Feb 21, 2014. doi: 10.3748/wjg.v20.i7.1746
Published online Feb 21, 2014. doi: 10.3748/wjg.v20.i7.1746
Table 1 Use of dietary supplement in the prevention of hepatic steatosis
Oil source | Oil fatty acid composition (%) | Experimental design | Results | Ref. | |
Krill | C14:0 C16:0 C18:0 C18:1 C18:2 C18:3 C20:5 C22:5 C22:6 | 2.5 18.2 2.8 25.8 54.4 4.9 5.3 2.3 3.0 | C57BL/6 mice fed for 8 wk with a high-fat diet containing 1.25%-5% krill oil | ↓ Hepatomegaly ↓ Hepatic steatosis ↓De novo lipogenesis ↓ Blood glucose | Tandy et al[50] |
Wistar rats fed for 6 wk with a diet containing 2.5% krill oil | ↓ Hepatic steatosis ↓De novo lipogenesis ↓ Haematic triglycerides ↓ Haematic cholesterol | Ferramosca et al[43] | |||
Sprague-Dawley rats fed for 12 wk with a high-fat diet containing 2.5% krill oil | ↓ Hepatic steatosis ↓De novo lipogenesis ↑ Fatty acid oxidation ↓ Mitochondrial uncoupling ↓ Haematic glucose ↓ Haematic insulin ↓ Haematic triglycerides | Ferramosca et al[42] | |||
Pine nut | C16:0 C18:0 C18:1 C18:2 C18:3 C18:3 (5,9,12) | 8.0 2.2 23.2 51.1 2.1 8.8 | Mice fed for 8 wk with a diet containing 7.5% pine nut oil | ↓ Liver weight ↓ Hepatic steatosis ↓De novo lipogenesis ↓ Haematic triglycerides ↓ Haematic cholesterol | Ferramosca et al[40] |
- Citation: Ferramosca A, Zara V. Modulation of hepatic steatosis by dietary fatty acids. World J Gastroenterol 2014; 20(7): 1746-1755
- URL: https://www.wjgnet.com/1007-9327/full/v20/i7/1746.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i7.1746